{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:06:05Z","timestamp":1781834765066,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.parkreldis.2007.11.003","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T11:59:41Z","timestamp":1205409581000},"page":"407-414","source":"Crossref","is-referenced-by-count":78,"title":["Efficacy and safety of purified botulinum toxin type A (Dysport\u00ae) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial"],"prefix":"10.1016","volume":"14","author":[{"given":"Daniel","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Comella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Ondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2007.11.003_bib1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.46.5.1213","article-title":"Blepharospasm: report of a workshop","volume":"46","author":"Hallett","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib2","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1001\/jama.248.23.3160","article-title":"Blinking and blepharospasm. Mechanism, diagnosis, and management","volume":"248","author":"Jankovic","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00002341-199809000-00002","article-title":"Blepharospasm: past, present, and future","volume":"14","author":"Anderson","year":"1998","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004356-199703000-00004","article-title":"Blepharospasm: an Australian survey","volume":"20","author":"Daly","year":"1997","journal-title":"Int J Rehabil Res"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00415-002-0733-1","article-title":"The impact of blepharospasm and cervical dystonia on health-related quality of life and depression","volume":"249","author":"Muller","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-0404.2001.00109.x","article-title":"Quality of life in patients with blepharospasm","volume":"103","author":"Tucha","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s004150070094","article-title":"A prevalence study of primary dystonia in eight European countries","volume":"247","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mds.1275","article-title":"Epidemiology of primary blepharospasm","volume":"17","author":"Defazio","year":"2002","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.parkreldis.2007.11.003_bib9","article-title":"Botulinum toxin type A therapy for blepharospasm","author":"Costa","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.parkreldis.2007.11.003_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-1331.2006.01441.x","article-title":"Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations","volume":"13","author":"Bhidayasiri","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib11","first-page":"24","article-title":"Treatment of blepharospasm with medication, surgery and type A botulinum toxin","volume":"22","author":"Arthurs","year":"1987","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/bjo.71.9.664","article-title":"Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections","volume":"71","author":"Elston","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib15","first-page":"67","article-title":"Treatment of blepharospasm with botulinum A toxin injections","volume":"129","author":"Bihari","year":"1988","journal-title":"Orv Hetil"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib16","first-page":"223","article-title":"Botulinum toxin in the treatment of facial dyskinesias","volume":"20","author":"Chong","year":"1991","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000008121","article-title":"Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study","volume":"43","author":"Rollnik","year":"2000","journal-title":"Eur Neurol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib18","first-page":"957","article-title":"Treatments by local injections of botulinum toxin in neurology. Indications and results","volume":"22","author":"Soulayrol","year":"1993","journal-title":"Presse Med"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib19","first-page":"121","article-title":"Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm","volume":"41","author":"Thomas","year":"1993","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib20","first-page":"206","article-title":"Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation","volume":"47","author":"Thussu","year":"1999","journal-title":"Neurol India"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib21","first-page":"61","article-title":"Quantitative assessment of efficacy of Dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm","volume":"14","author":"Tsai","year":"2005","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin","volume":"18","author":"Van den Bergh","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm","volume":"235","author":"Nussgens","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","article-title":"DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A \u2013 Dysport and Botox \u2013 assuming a ratio of 4:1","volume":"12","author":"Sampaio","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm","volume":"113","author":"Roggenkamper","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib26","first-page":"97","article-title":"Rating scales for blepharospasm","volume":"4","author":"Fahn","year":"1985","journal-title":"Adv Ophthal Plast Reconstr Surgery"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mds.870100407","article-title":"The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm","volume":"10","author":"Lindeboom","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib28","doi-asserted-by":"crossref","first-page":"1347S","DOI":"10.1177\/00928615980320S131","article-title":"Multiple testings: multiple comparisons and multiple endpoints","author":"Chi","year":"1998","journal-title":"Drug Inf J"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archopht.1984.01040031184014","article-title":"Treatment of blepharospasm with botulinum toxin. A preliminary report","volume":"102","author":"Frueh","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-6420(86)33785-0","article-title":"The use of botulinum toxin in the medical management of benign essential blepharospasm","volume":"93","author":"Perman","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.53.8.633","article-title":"Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm","volume":"53","author":"Jankovic","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib32","first-page":"133","article-title":"Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study","volume":"26","author":"Taylor","year":"1991","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02340723","article-title":"Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group","volume":"14","author":"Berardelli","year":"1993","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib34","first-page":"424","article-title":"Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose\u2013response study measuring eyelid force","volume":"39","author":"Iwashige","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib35","first-page":"281","article-title":"Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients","volume":"78","author":"Poungvarin","year":"1995","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1442-9071.1998.tb01527.x","article-title":"Facial muscle spasms: an Australian study","volume":"26","author":"Kowal","year":"1998","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib37","first-page":"279","article-title":"Treatment of dystonia with botulinum A toxin: a retrospective study of 170 patients","volume":"4","author":"Kwan","year":"1998","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/01676830490506041","article-title":"Impact on quality of life of botulinum toxin treatments for essential blepharospasm","volume":"23","author":"MacAndie","year":"2004","journal-title":"Orbit"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-6420(97)30220-6","article-title":"Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections","volume":"104","author":"Price","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mds.20468","article-title":"Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study","volume":"20","author":"Marchetti","year":"2005","journal-title":"Mov Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.parkreldis.2007.11.003_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/PL00007813","article-title":"Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm","volume":"248","author":"Jost","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0004-282X2005000200006","article-title":"Botulinum toxin A in the treatment of blepharospasm: a 10-year experience","volume":"63","author":"Silveira-Moriyama","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.parkreldis.2007.11.003_bib43","first-page":"125","article-title":"Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm","volume":"18","author":"Thill","year":"1991","journal-title":"Acta Med Austriaca"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007002386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007002386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T02:55:31Z","timestamp":1546224931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802007002386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1353802007002386"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2007.11.003","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}